Yaron Eldad - 18 Mar 2026 Form 3 Insider Report for Evogene Ltd. (EVGN)

Reporting relationship: Chief Financial Officer
Issuer ticker: EVGN
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:09:07 UTC
Source filing: View source filing
Reporting owner signature: /s/ Nitsan Deutsch, attorney-in-fact

Key filing fact

Yaron Eldad filed Form 3 for Evogene Ltd. (EVGN) on 18 Mar 2026.

Key facts

This page summarizes Yaron Eldad's Form 3 filing for Evogene Ltd. (EVGN).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 08:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001408407 Primary reporting owner

ELDAD YARON

Relationship: Chief Financial Officer
Address: 30 HAIRIT ST., MAALE ADUMIM, ISRAEL
Signature: /s/ Nitsan Deutsch, attorney-in-fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVGN holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,100
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVGN holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 15,000
Exercise price: $12.58
Footnotes: F2

EVGN holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 60,000
Exercise price: $2.30
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The ordinary shares reported in this row consist of 4,100 ordinary shares underlying restricted share units ("RSUs") that were granted to the Reporting Person and that commenced vesting on April 1, 2023 and vest and become exercisable on an equal, quarterly basis (6.25% per quarter) over a four-year period such that they will be fully vested on the four-year anniversary of the grant date.

Footnote F2

The options reported in this row vest and become exercisable over a period of four years from the March 30, 2022 vesting commencement date: 25% of the options vested upon the one-year anniversary of the vesting commencement date, and the remaining options vest on an equal quarterly basis (6.25% per quarter) over the following twelve quarters such that all options will be fully vested and exercisable on the four-year anniversary of the vesting commencement date.

Footnote F3

The options reported in this row vest and become exercisable over a period of four years from the November 20, 2024 vesting commencement date, on an equal, quarterly basis (6.25% per quarter), such that they will be fully vested on the four-year anniversary of the grant date.

SEC remarks

Exhibit 24.1 - Power of Attorney.